BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 15642396)

  • 1. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
    Saunders K; Czepulkowski B; Sivalingam R; Hayes JP; Aldouri M; Sekhar M; Cummins M; Ho A; Mufti GJ
    Cancer Genet Cytogenet; 2005 Jan; 156(2):154-7. PubMed ID: 15642396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two contrasting recurrent isochromosomes 20 found in myelodysplastic syndromes suggests that retention of proximal 20q is a significant factor in myeloid malignancies.
    MacKinnon RN; Campbell LJ
    Cancer Genet Cytogenet; 2005 Dec; 163(2):176-9. PubMed ID: 16337864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome.
    Douet-Guilbert N; Laï JL; Basinko A; Gueganic N; Andrieux J; Pollet B; Plantier I; Delattre C; Crépin O; Corm S; Le Bris MJ; Morel F; De Braekeleer M
    Br J Haematol; 2008 Dec; 143(5):716-20. PubMed ID: 19036015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FISH studies identify the i(20q-) anomaly as a der(20)del(20)(q11q13)idic(20)(p11).
    Li T; Xue Y; Wu Y; Pan J
    Genes Chromosomes Cancer; 2006 Jun; 45(6):536-9. PubMed ID: 16506189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-).
    Li T; Xue Y; Wu Y; Pan J
    Br J Haematol; 2004 May; 125(3):337-42. PubMed ID: 15086414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study.
    Mullier F; Daliphard S; Garand R; Dekeyser M; Cornet Y; Luquet I; Talmant P; Richebourg S; Jamar M; Dogné JM; Chatelain C; Michaux L; Chatelain B
    Ann Hematol; 2012 Feb; 91(2):203-13. PubMed ID: 21744002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and molecular cytogenetic features of myeloid diseases characterized by i(20q-): a study of seven cases].
    Li TY; Xue YQ; Wu YF; Pan JL; Liu DD; Gong SL
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):732-5. PubMed ID: 15200909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and experimental study of two cases of myelodysplastic syndromes with double isochromosome 20q- anomaly].
    Gong SL; Xue YQ; Wang JM; Han FL; Xu YQ; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):35-8. PubMed ID: 15946507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Report of ten cases of hematologic malignancies with idic(20q-) and literature review].
    Han YS; Xue YQ; Li TY; Zhang J; Chen SN; Pan JL; Wu YF; Wang Y; Shen J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):17-20. PubMed ID: 21429395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isochromosome of a deleted 20q may be a relatively common abnormality in myeloid malignancies.
    Ligon AH; DeAngelo DJ; Atkins L; Dal Cin P
    Cancer Genet Cytogenet; 2005 Oct; 162(1):89-91. PubMed ID: 16157208
    [No Abstract]   [Full Text] [Related]  

  • 14. Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.
    Smoley SA; Fink SR; Paternoster SF; Stockero KJ; Nguyen LP; Nguyen PL; Hanson CA; Dewald GW
    Cancer Genet Cytogenet; 2007 Mar; 173(2):144-9. PubMed ID: 17321330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies.
    Maserati E; Pressato B; Valli R; Minelli A; Sainati L; Patitucci F; Marletta C; Mastronuzzi A; Poli F; Lo Curto F; Locatelli F; Danesino C; Pasquali F
    Br J Haematol; 2009 Apr; 145(2):190-7. PubMed ID: 19222471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray CGH analyses of chromosomal 20q deletions in patients with hematopoietic malignancies.
    Okada M; Suto Y; Hirai M; Shiseki M; Usami A; Okajima K; Teramura M; Mori N; Motoji T
    Cancer Genet; 2012; 205(1-2):18-24. PubMed ID: 22429594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary alveolar proteinosis as a terminal complication in a case of myelodysplastic syndrome with idic(20q-).
    Xue Y; Han Y; Li T; Chen S; Zhang J; Pan J; Wu Y; Wang Y; Shen J
    Acta Haematol; 2010; 123(1):55-8. PubMed ID: 19955712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refinement of the commonly deleted segment in myeloid leukemias with a del(20q).
    Wang PW; Iannantuoni K; Davis EM; Espinosa R; Stoffel M; Le Beau MM
    Genes Chromosomes Cancer; 1998 Feb; 21(2):75-81. PubMed ID: 9491317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
    Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
    Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.